Form 8-K - Current report:
SEC Accession No. 0001493152-24-051060
Filing Date
2024-12-20
Accepted
2024-12-20 16:15:31
Documents
13
Period of Report
2024-12-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50341
  Complete submission text file 0001493152-24-051060.txt   227870

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abeo-20241220.xsd EX-101.SCH 3045
3 XBRL LABEL FILE abeo-20241220_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE abeo-20241220_pre.xml EX-101.PRE 24185
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3679
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 241568141
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)